Liz Neporent
Producer at ABC News
ABC News Med Unit | Truth seeking health #journalist | Pathological #runner | Former Medscape/WebMD
Articles
-
1 week ago |
abcnews.go.com | Liz Neporent |Jenny Wagnon Courts |Lucien Bruggeman
President Trump's NIH funding cuts had threatened to derail the promising trial. ByLiz Neporent, Jenny Wagnon Courts, and Lucien BruggemanNIH researcher Dr. Steven Rosenberg is seen in his lab. ABC NewsA promising government-funded cancer trial is back in motion after budgetary and workforce cuts imposed by the Trump administration threatened to derail its progress, the trial's lead researcher told ABC News on Thursday.
-
2 months ago |
thepulseofnh.com | Youri Benadjaoud |Mary Kekatos |Liz Neporent |Megan Forrester
(NEW YORK) -- Flu activity remains "elevated" in the United States but is starting to show signs of abating, according to new federal data published Friday. The 2024-25 flu season was classified by the Centers for Disease Control and Prevention (CDC) as a "high" severity season overall and for all age groups, making it the firstseason since 2017-2018. During the week ending Feb.
-
2 months ago |
thepulseofnh.com | Mary Kekatos |Youri Benadjaoud |Liz Neporent |Megan Forrester
(AUSTIN, Texas) -- The number of measles cases linked to an outbreak in western Texas has grown to 90, according to new data released on Friday. Almost all of the cases are in unvaccinated individuals or individuals whose vaccination status is unknown, and 16 people have been hospitalized so far, according to the Texas Department of State Health Services. Five cases included those who have been vaccinated.
-
2 months ago |
southernillinoisnow.com | Liz Neporent |Megan Forrester
(NEW YORK) — A personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery, according to a preliminary study published Wednesday in the journal Nature. Pancreatic cancer is one of the most aggressive cancers, with a typical survival rate of only about a year after the diagnosis according to the study.
-
2 months ago |
thepulseofnh.com | Liz Neporent |Megan Forrester |Mary Kekatos
(NEW YORK) -- A personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery, according to a preliminary study published Wednesday in the journal Nature. Pancreatic cancer is one of the most aggressive cancers, with a typical survival rate of only about a year after the diagnosis according to the study.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 25K
- Tweets
- 12K
- DMs Open
- Yes